Exagen Inc (XGN): Next-Year EPS Estimate 27.67%
As of 2026-06-11, Exagen Inc (XGN) has a next-year EPS growth estimate of 27.67%.
On 2026-05-12, analyst consensus for XGN's next-year EPS growth shifted from 30.75% to 27.67% — a negative change of 3.08 percentage points. The revised estimate has been sustained across 23 subsequent trading sessions. Current-year growth is projected at 26.73%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 27.67%
- EPS growth this year
- 26.73%
- EPS next quarter (est)
- -$0.19
- Last price
- $4.48
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 27.67% | 26.73% | -$0.19 | $4.48 |
| 2026-06-10 | 27.67% | 26.73% | -$0.19 | $4.19 |
| 2026-06-09 | 27.67% | 26.73% | -$0.19 | $4.31 |
| 2026-06-08 | 27.67% | 26.73% | -$0.19 | $4.20 |
| 2026-06-07 | 27.67% | 26.73% | -$0.19 | $4.29 |
| 2026-06-04 | 27.67% | 26.73% | -$0.19 | $4.79 |
| 2026-06-03 | 27.67% | 26.73% | -$0.19 | $4.54 |
| 2026-06-02 | 27.67% | 26.73% | -$0.19 | $4.82 |
| 2026-06-01 | 27.67% | 26.73% | -$0.19 | $5.35 |
| 2026-05-31 | 27.67% | 26.73% | -$0.19 | $4.98 |
| 2026-05-28 | 27.67% | 26.73% | -$0.19 | $5.08 |
| 2026-05-27 | 27.67% | 26.73% | -$0.19 | $5.01 |
| 2026-05-26 | 27.67% | 26.73% | -$0.19 | $4.62 |
| 2026-05-25 | 27.67% | 26.73% | -$0.19 | $4.26 |
| 2026-05-24 | 27.67% | 26.73% | -$0.19 | $4.26 |
| 2026-05-21 | 27.67% | 26.73% | -$0.19 | $4.27 |
| 2026-05-20 | 27.67% | 26.73% | -$0.19 | $3.83 |
| 2026-05-19 | 27.67% | 26.73% | -$0.19 | $3.73 |
| 2026-05-18 | 27.67% | 26.73% | -$0.19 | $3.49 |
| 2026-05-17 | 27.67% | 26.73% | -$0.19 | $3.64 |
| 2026-05-14 | 27.67% | 26.73% | -$0.19 | $3.85 |
| 2026-05-13 | 27.67% | 26.73% | -$0.19 | $3.49 |
| 2026-05-12 | 27.67% | 26.73% | -$0.19 | $3.71 |
| 2026-05-11 | 30.75% | 22.98% | -$0.19 | $3.98 |
| 2026-05-10 | 34.60% | 21.20% | -$0.23 | $2.95 |
| 2026-05-07 | 34.60% | 21.20% | -$0.23 | $2.94 |
| 2026-05-06 | 34.60% | 21.20% | -$0.23 | $3.09 |
| 2026-05-05 | 34.60% | 21.20% | -$0.23 | $3.09 |
| 2026-05-04 | 34.60% | 21.20% | -$0.23 | $3.10 |
| 2026-05-03 | 34.60% | 21.20% | -$0.23 | $3.06 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Exagen Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Exagen Inc (XGN) has a next-year EPS growth estimate of 27.67%, based on analyst consensus.
When was the latest EPS estimate revision for XGN?▾
The most recent revision occurred on 2026-05-12, when analysts adjusted the next-year EPS growth estimate from 30.75% to 27.67%.
What sector and industry does Exagen Inc belong to?▾
Exagen Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. XGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Exagen Inc (XGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports